查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1280599

靜脈注射用溶液的全球市場

Intravenous (IV) Solutions
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 487 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

靜脈注射用溶液的全球市場在2030年前將達到217億美元

在COVID-19後改變的商務環境中，2022年122億美元的靜脈注射用溶液的全球市場在2030年前將達到217億美元，在2022年～2030年預計將以年複合成長率7.5％的速度成長。本報告所分析之市場區隔之一的非口服營養劑年複合成長率將記錄7.9％，到分析期間結束時將達到151億美元。考慮疫情後的復甦趨勢，末梢非口服營養劑市場區隔的成長今後8年的年複合成長率將修正為6.6％。

美國市場估算為47億美元，中國則將以年複合成長率9％增長

美國的靜脈注射用溶液市場在2022年估算為47億美元。作為世界第2大經濟大國的中國，在2022年～2030年年複合成長率預計將為9％，2030年達到22億美元的市場規模。其他熱門的地區市場有日本和加拿大，在2022年～2030年預計將各以6.3％和7.1％的速度成長。在歐洲市場中，德國以年複合成長率7.4％成長。

調查對像企業範例

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Allergan PLC
  • AMAG Pharmaceuticals, Inc.
  • Fresenius SE & Co. KGaA
  • Apria Healthcare Group, Inc.
  • American Regent, Inc.
  • Ajinomoto Health & Nutrition North America, Inc.
  • DRINKmaple
  • Earth Science Tech
  • Calea Limited
  • Enduropacks, Inc.
  • DexTech Medical

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東
  • 非洲

第4章 競爭

簡介目錄
Product Code: MCP22111

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Intravenous (IV) Solutions Market to Reach $21.7 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Intravenous (IV) Solutions estimated at US$12.2 Billion in the year 2022, is projected to reach a revised size of US$21.7 Billion by 2030, growing at aCAGR of 7.5% over the period 2022-2030. Parenteral Nutrition, one of the segments analyzed in the report, is projected to record 7.9% CAGR and reach US$15.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Peripheral Parenteral Nutrition segment is readjusted to a revised 6.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.7 Billion, While China is Forecast to Grow at 9% CAGR

The Intravenous (IV) Solutions market in the U.S. is estimated at US$4.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.3% and 7.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR.

Select Competitors (Total 82 Featured) -

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Allergan PLC
  • AMAG Pharmaceuticals, Inc.
  • Fresenius SE & Co. KGaA
  • Apria Healthcare Group, Inc.
  • American Regent, Inc.
  • Ajinomoto Health & Nutrition North America, Inc.
  • DRINKmaple
  • Earth Science Tech
  • Calea Limited
  • Enduropacks, Inc.
  • DexTech Medical

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Economic Update
    • From Pandemic to War & Inflation: "Gloomy Outlook for 2023 Despite Signs of Easing Inflationary Conditions
    • Here's How Inflationary Pressures Affect the Economy
    • Russia-Ukraine War, the Primary Culprit Responsible for the Hardships
    • Although Past Peak in 2023, Efforts to Solve the Inflation Puzzle Should Continue
    • Here's What's Causing Inflationary Pressures in the Global Market
    • Shaken by the War, Global Oil Prices Spiral and Feed Inflationary Pressures, Guiding the World Towards a Cost of Living Crisis: Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2017 through 2024
    • War-Induced Commodity Price Increases & Broad Based Price Pressures Mark the Return of Global Inflation to the Highest Level Seen Since 1996: Global Inflation Rates (In %) for the Years 2019 Through 2024
    • Although Facing a Lower Recession Risk, Global Economic Growth in 2023 to Slowdown Amid War, Inflation, Elevated Interest Rates & Marginal Easing of Inflation: World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2020 Through 2024
    • Recession Triggered by Uncontrolled Inflation or Unemployment, Which is the Greater Evil? Inflation Battling Policy Measures to Slowdown Post Pandemic Recovery in Unemployment Rates: Global Number of Unemployed People (In Million) for Years 2019 Through 2024
    • Pandemic Affects Demand for Intravenous Solutions
    • Elective Surgeries Suffer Amid COVID-19, Affecting Demand for IV Solutions
    • COVID-19 Induced YOY Decline in Heart Surgery Volumes in the US in 2020
    • COVID-19 Results in Colossal Backlog of Elective Surgeries & Extended Waiting Times
    • Competition
    • Intravenous (IV) Solutions - Global Key Competitors Percentage Market Share in 2023 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
    • An Introduction to Intravenous (IV) Solutions
    • Types of Intravenous Solutions
    • Global Market Prospects & Outlook
    • TPN Emerges as the Largest Segment in the IV Solutions Market
    • Single Dose Amino Acid Solutions: The Major Nutrient Type
    • Developed Economies Lead, Developing Regions to Propel Future Growth
    • World Brands
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Prominent Trends to Watch-For in Intravenous Solutions Arena
    • Intravenous Therapy Faces Supply Shortages in the US
    • Sudden Shortage of Sodium Chloride Solutions from COVID
    • Medical Plastic Shortages Add to the Supply Woes
    • Resources for Healthcare Providers
    • Aging Global Demography and Resultant Rise in Need for Nutrition Management Augurs Well for the Market Growth
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Growing Prevalence of Malnutrition in Hospitalized Patients to Fuel Need for IV Solutions
    • Daily Requirements for Adults (Male and Female) by Nutrient Type
    • Energy Requirements by Age and Gender
    • Intravenous Fluids: The Lifeblood of Modern Healthcare
    • Rising Prevalence of Chronic Diseases and Resultant Need for Additional Nutrition Enhances Need to Administer IV Solutions
    • Rising Cancer Incidence and Need for Nutritional Support
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2020
    • Number of New Cancer Cases and Deaths (in Million) by Region for 2020
    • Alarming Rise in Diabetes Incidence Worldwide
    • World Diabetes and Population Statistics (2019, 2030 & 2045)
    • World Diabetes Prevalence (2000-2045)
    • Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
    • Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
    • Unrelenting Threat of HIV/AIDS Infection
    • Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2020
    • Number of AIDS-Related Deaths (in Thousands) by Region for 2018
    • Nutritional Management of Patients with Neurological Diseases
    • Burden of Neurological Diseases: Deaths Per 100,000 Population due to Neurological Conditions in Select Countries
    • Concerns over Fluid Depletion from Body Due to GI & Diarrheal Diseases Necessitate IV Fluid Administration
    • Growing Numbers of Pre-term Births Drives Demand for IV Solutions
    • Top Countries Ranked by Most Number of Preterm Births
    • Countries with Highest Preterm Birth Rates: Number of Preterm Births Per 100 Live Births by Top Countries
    • Demand Rises for Home Intravenous Nutritional Therapies
    • Premixed IV Nutrition: A Step towards Safer Medication Practices
    • Premixed Formulations Present Efficient Delivery System
    • Iron Replacement Therapies: Potential for Growth
    • Growing Demand for Low-Cost Intravenous Nutrition Solutions
    • COVID-19 Outbreak: Combating Medication Errors in IV Infusion
    • Increasing Healthcare Expenditure Creates Conducive Environment
    • World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 & 2023
    • Challenges Confronting IV Solutions Market
    • Issues with Traditional IV Tubing
    • Multi-Lumen IV Tubing to the Rescue
    • Innovative Multi-Lumen Tubing to Rethink IV Administration & Patient Experience
    • The Future of Smart Infusion Pumps for Intravenous Therapy Looks Bright
    • IV Solutions for Hypernatremia
    • Albumin (Human) Injection for Hypovolemia Treatment
    • Rising Focus on Blow-Fill-Seal Technology
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intravenous (IV) Solutions Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intravenous (IV) Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 4: World 16-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 7: World 16-Year Perspective for Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Peripheral Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Peripheral Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 10: World 16-Year Perspective for Peripheral Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Single Dose Amino Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Single Dose Amino Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 13: World 16-Year Perspective for Single Dose Amino Acids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vitamins & Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Vitamins & Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 16: World 16-Year Perspective for Vitamins & Minerals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 19: World 16-Year Perspective for Carbohydrates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Parenteral Lipid Emulsion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Parenteral Lipid Emulsion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for Parenteral Lipid Emulsion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Nutrients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Nutrients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Nutrients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • JAPAN
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • CHINA
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: China 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: China 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • EUROPE
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Intravenous (IV) Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • FRANCE
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: France 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: France 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • GERMANY
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Intravenous (IV) Solutions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • INDIA
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: India 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: India 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Intravenous (IV) Solutions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Intravenous (IV) Solutions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030
  • AFRICA
    • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Intravenous (IV) Solutions by Type - Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2014, 2023 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2014, 2023 & 2030

IV. COMPETITION